MuellerCMasriBHoggJMastrogiocomoMChiuT-L. Carbohydrate versus fat controlled diet effect on weight loss and coronary artery disease risk: a pilot feeding study. Nutr Clin Pract. 2010;25:542-547.
2.
KassirerJAngellM. Losing weight—an ill-fated New Year’s resolution. N Engl J Med. 1998;338:52-54.
3.
StunkardAJMcLaren-HumeM. The results of treatment for obesity. Arch Intern Med. 1959;103:79-85.
4.
MarkAL. Dietary therapy for obesity: an emperor with no clothes. Hypertension. 2008;51:1426-1434.
5.
BarnesPMHeymanKMFreemanGSchillerJS. Early Release of Selected Estimates Based on Data From the 2009 National Health Interview Survey. Hyattsville, MD: National Center for Health Statistics; June16, 2010.
6.
BiltekoffC. Consumer response: the paradoxes of food and health. Ann NY Acad Sci. 2010;1190:174-178.
7.
KirkSFLPenneyTLMcHughTLF. Characterizing the obesogenic environment: the state of the evidence with directions for future research. Obesity Rev. 2010;11:109-117.
8.
LudwigDSNestleM. Can the food industry play a constructive role in the obesity epidemic?JAMA. 2008;300:1808-1811.
9.
LudwigDSPollackHA. Obesity and the economy: from crisis to opportunity. JAMA. 2009;301:533-535.
10.
CliftonPM. Dietary treatment for obesity. Nat Rev Gastroenterol Hepatol. 2008;5:672-681.
11.
KumanyikaSKObarzanekEStettlerN. Population-based prevention of obesity: the need for comprehensive promotion of healthful eating, physical activity, and energy balance: a scientific statement from American Heart Association Council on Epidemiology and Prevention, Interdisciplinary Committee for Prevention (formerly the Expert Panel on Population and Prevention Science). Circulation. 2008;118:428-464.
12.
BlackburnGLWollnerSHeymsfieldSB. Lifestyle interventions for the treatment of class III obesity: a primary target for nutrition medicine in the obesity epidemic. Am J Clin Nutr. 2010;91(suppl):289S-292S.
13.
BrayGKushnerRRyanDAronneL. The Obesity Epidemic! Exploring Emerging Strategies for Weight Control and Risk Reduction. Presented at the Marriott Wardman Park Hotel, Washington, DC, October 26, 2009. Transcript available at http://cme.medscape.com/viewarticle/712986_transcript. Accessed July 1, 2010.
14.
WingRRPhelanS. Long-term weight loss maintenance. Am J Clin Nutr. 200582:222S-225S.
15.
WingRRHillJO. Successful weight loss maintenance. Annu Rev Nutr. 2001;21:323-341.
16.
PhelanSWyattHNasseryS. Three-year weight change in successful weight losers who lost weight on a low-carbohydrate diet. Obesity. 2007;15:2470-2477.
17.
MarkDH. Deaths attributable to obesity. JAMA. 2005;293:1918-1919.
18.
O’NeilCENicklasTA. Relationship between diet/ physical activity and health. Am J Lifestyle Med. 2007;1:457-481.
19.
StevensJMcClainJETruesdalePK. Commentary: obesity claims and controversies. Int J Epidemiol. 2006;35:77-78.
20.
FantuzziGMazzoneT. Adipose tissue and atherosclerosis: exploring the connection. Athero Thromb Vasc Biol. 2007;27:996-1003.
21.
ChamberlainJFrancisSBrookesZ. Interleukin-1 regulates multiple atherogenic mechanisms in response to fat feeding. PLoS ONE. 2009;4:e5073.
22.
LamonBDHajjarDP. Inflammation at the molecular interface of atherogenesis: an anthropological journey. Am J Pathol. 2008;173:1253-1264.
23.
LibbyPRidkerPMHanssonGK. Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol. 2009;54:2129-2138.
24.
StefanNKantartzisKMachannJ. Identification and characterization of metabolically benign obesity in humans. Arch Intern Med. 2008;168:1609-1616.
25.
FlegalKMGraubardBIWilliamsonDFMitchellHGailMH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293:1861-1867.
26.
RyanD. Risks and benefits of weight loss: challengers to obesity research. Eur Heart J. 2005;7(suppl L):L27-L31.
27.
KarelisADFarajMBastardJ-P. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab. 2005;90:4145-4150.
28.
ÄrnlövJIngelssonESundströmJLindL. Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010;121:230-236.
29.
LeeI-MDjousséLSessoHDWangLBuringJE. Physical activity and weight gain prevention. JAMA. 2010;303:1173-1179.
30.
ThompsonPDBuchnerDPiñaIL. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Arterioscler Thromb Vasc Biol. 2003;23:e42-e49.
31.
HamerMSteptoeA. Prospective study of physical fitness, adiposity, and inflammatory markers in healthy middle-aged men and women. Am J Clin Nutr. 2009;89:85-89.
32.
Larson-MeyerDERedmanLHeilbronnLKMartinCKRavussinE. Caloric restriction with or without exercise: the fitness versus fatness debate. Med Sci Sports Exerc. 2010;42:152-159.
33.
DuncanGE. The “fit but fat” concept revisited: population-based estimates using NHANES. Int J Behav Nutr Phys Act. 2010;7:47.
34.
KonesR. After cardiac surgery, how does nutrition fit in with risk factors?JPEN J Parenter Enteral Nutr. 2010;34:163-167.
35.
Van GaalLFMertensILBallauxD. What is the relationship between risk factor reduction and degree of weight loss?Eur Heart J. 2005;7(suppl L):L21-L26.
36.
BlairSNKohlHWIIIBarlowCE. Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA. 1995;273:1093-1098.
37.
Lloyd-JonesDAdamsRJBrownTM; on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121:e46-e215.
38.
Health, United States, 2009: With Special Feature on Medical Technology. Hyattsville, MD: National Center for Health Statistics; 2010.
39.
PopkinBM. Recent dynamics suggest selected countries catching up to US obesity. Am J Clin Nutr. 2010;91(suppl):284S-288S.
KonesRPhillipsJH. Prevention of heart cell death. In: YuPNGoodwinJF, eds. Progress in Cardiology. Vol 4. Philadelphia, PA: Lea & Febiger; 1975:199-224.
42.
MarkkuL. Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008. Diabetes Care. 2010;33:442-449.
43.
CapewellSFordESCroftJBCritchleyJAGreenlundKJLabartheDR. Cardiovascular risk factor trends and potential for reducing coronary heart disease mortality in the United States of America. Bull World Health Organ. 2010;88:120-130.
44.
Department of Health and Human Services. Healthy people 2010: understanding and improving health and objectives for improving health. Washington, DC: Government Printing Office; 2010. http://www.cdc.gov/nchs/healthy_people.htm. Accessed June 9, 2010.
45.
FordESAjaniUACroftJB. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med. 2007;356:2388-2398.
46.
FordESCapewellS. Coronary heart disease mortality among young adults in the U.S. from 1980 through 2002: concealed leveling of mortality rates. J Am Coll Cardiol. 2007;50:2128-2132.
47.
FryarCDHirschREberhardtMSYoonSSWrightJD. Hypertension, High Serum Total Cholesterol, and Diabetes: Racial and Ethnic Prevalence Differences in U.S. Adults, 1999-2006. Data Brief No. 36. Hyattsville, MD: National Center for Health Statistics; April2010.
48.
Lloyd-JonesDAdamsRCarnethonM. Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:e21-e181.
49.
HingoraniADPsatyBM. Primary prevention of cardiovascular disease: time to get more or less personal?JAMA. 2009;302:2144-2145.
50.
MarmaAKBerryJDNingHPersellSDLloyd-JonesDM. Distribution of 10-year and lifetime predicted risks for cardiovascular disease in US adults: findings from the National Health and Nutrition Examination Survey 2003 to 2006. Circ Cardiovasc Qual Outcomes. 2010;3:8-14.
51.
Lloyd-JonesDMHongYLabartheD; on behalf of the American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121:586-613.
52.
RoseG. Incubation period of coronary heart disease. Int J Epidemiol. 2005;34:242-244.
53.
RoseG. The Strategy of Preventive Medicine. Oxford, UK: Oxford University Press; 1992.
54.
CannonCPBraunwaldEMcCabeCH. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med. 2004;350:1495-1504.
55.
LibbyP. The forgotten majority: unfinished business in cardiovascular risk reduction. J Am Coll Cardiol. 2005;46:1225-1228.
56.
AllaVMKaushikMMoossA. Targeting residual risk: the rationale for the use of non-HDL cholesterol. South Med J. 2010;103:434-437.
57.
KonesR. Recent advances in the management of chronic stable angina, I: approach to the patient, diagnosis, pathophysiology, risk stratification, and gender disparities. Vasc Health Risk Manag. 2010; 6:653-656.
58.
EifertSMairHBoulesteixA-L. Mid-term outcomes of patients with PCI prior to CABG in comparison to patients with primary CABG. Vasc Health Risk Manag. 2010;6:495-501.
59.
HataMTakayamaTSezaiAYoshitakeIHirayamaAMinamiK. Efficacy of aggressive lipid controlling therapy for preventing saphenous vein graft disease. Ann Thorac Surg. 2009;88:1440-1444.
60.
GouldKLOrnishDKirkeeideR. Improved stenosis geometry by quantitative coronary arteriography after vigorous risk factor modification. Am J Cardiol.1992;69:845-853.
61.
GouldKLOrnishDScherwitzL. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification. JAMA. 1995;274:894-901.
62.
OrnishDScherwitzLWBillingsJH. Intensive lifestyle changes for reversal of coronary heart disease. JAMA. 1998;280:2001-2007.
63.
BantingW. Letter on Corpulence. Addressed to the Public. 3rd ed.London, England: Harrison; 1864.
64.
AtkinsRC. Dr Atkins’ New Diet Revolution. New York, NY: Harper Collins; 2002.
65.
DenaMBravataDMSandersL. Efficacy and safety of low-carbohydrate diets: a systematic review. JAMA. 2003;289:1837-1850.
66.
BrehmBJSeeleyRJDanielsSRD’AlessioDA. A randomized trial comparing a very low carbohydrate diet and a calorie-restricted low fat diet on body weight and cardiovascular risk factors in healthy women. J Clin Endocrinol Metab. 2003;88:1617-1623.
67.
FosterGDWyattHRHillJO. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med. 2003;348:2082-2090.
68.
SamahaFFIqbalNSeshadriP. A low-carbohydrate as compared with a low-fat diet in severe obesity. N Engl J Med. 2003;348:2074-2081.
69.
DansingerMLGleasonJAGriffithJLSelkerHPSchaeferEJ. Comparison of the Atkins, Ornish, Weight Watchers, and Zone diets for weight loss and heart disease risk reduction: a randomized trial. JAMA. 2005;293:43-53.
70.
GardnerCDKiazandAAlhassanS. Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA. 2007;297:969-977.
71.
HeymsfieldSBBlackburnGL. Comparison of weight-loss diets. JAMA. 2007;298:173-174.
72.
ShaiISchwarzfuchsDHenkinY; for the Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359:229-241.
73.
DueALarsenTMHuilingMHermansenKStenderSAstrupA. Comparison of 3 ad libitum diets for weight-loss maintenance, risk of cardiovascular disease, and diabetes: a 6-mo randomized, controlled trial. Am J Clin Nutr. 2008;88:1232-1241.
74.
PolychronopoulosEPounisGBountzioukaV. Dietary meat fats and burden of cardiovascular disease risk factors, in the elderly: a report from the MEDIS study. Lipids Health Dis. 2010;9:30.
75.
SinhaRCrossAJGraubardBILeitzmannMFSchatzkinA. Meat intake and mortality: a prospective study of over half a million people. Arch Intern Med. 2009;169:562-571.
76.
PopkinBM. Reducing meat consumption has multiple benefits for the world’s health. Arch Intern Med. 2009;169:543-545.
77.
FriedmanAN. High protein diets: potential effects on the kidney in renal health and disease. Am J Kidney Dis. 2004;44:950-962.
van DamRMWillettWCRimmEBStampferMJHuFB. Dietary fat and meat intake in relation to risk of type 2 diabetes in men. Diabetes Care. 2002;25:417-424.
80.
OrnishD. Mostly plants. Am J Cardiol.2009;104:957-958.
81.
HaltonTLWillettWCLiuS. Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med. 2006;355:1991-2002.
82.
HaltonTLLiuSMansonJEHuFB. Low-carbohydrate-diet score and risk of type 2 diabetes in women. Am J Clin Nutr. 2008;87:339-346.
83.
JoshipuraKJHuFBMansonJE. The effect of fruit and vegetable intake on risk for coronary heart disease. Ann Intern Med. 2001;134:1106-1114.
84.
HuFB. Plant-based foods and prevention of cardiovascular disease: an overview. Am J Clin Nutr. 2003;78(suppl):544S-551S.
85.
FerdowsianHRBarnardND. Effects of plant-based diets on plasma lipids. Am J Cardiol. 2009;104:947-956.
86.
DeMariaAN. Eat food, not very much, mostly plants. J Am Coll Cardiol. 2010;55:2288-2289.
87.
BrinkworthGDNoakesMBuckleyJDKeoghJBCliftonPM. Long-term effects of a very-low-carbohydrate weight loss diet compared with an isocaloric low-fat diet after 12 mo. Am J Clin Nutr. 2009;90:23-32.
88.
TayJBrinkworthGDNoakesMKeoghJCliftonPM. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol. 2008;51:59-67.
89.
NordmannAJNordmannABrielM. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:285-293.
90.
ShaiISpenceJDSchwarzfuchsD; for the DIRECT Group. Dietary intervention to reverse carotid atherosclerosis. Circulation. 2010;121:1200-1208.
91.
BonettiPOLermanLOLermanA. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol. 2003;23:168-175.
92.
DeanfieldJEHalcoxJPRabelinkTJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation. 2007;115:1285-1295.
93.
PierceGLBeskeSDLawsonBR. Weight loss alone improves conduit and resistance artery endothelial function in young and older overweight/obese adults. Hypertension. 2008;52:72-79.
94.
KeoghJBBrinkworthGDNoakesMBelobrajdicDPBuckleyJDCliftonPM. Effects of weight loss from a very-low-carbohydrate diet on endothelial function and markers of cardiovascular disease risk in subjects with abdominal obesity. Am J Clin Nutr. 2008;87:567-576.
95.
PhillipsSAJurvaJWSyedAQ. Benefit of low-fat over low-carbohydrate diet on endothelial health in obesity. Hypertension. 2008;51:376-382.
96.
MillerMBeachVSorkinJD. Comparative effects of three popular diets on lipids, endothelial function, and C-reactive protein during weight maintenance. J Am Diet Assoc. 2009;109:713-717.
97.
SpenceBMCourtneyCHMcKinleyMC. Low-fat versus low-carbohydrate weight reduction diets: effects on weight loss, insulin resistance, and cardiovascular risk: a randomized control trial. Diabetes. 2009;58:2741-2748.
98.
VlachopoulosCAznaouridisKStefanadisC. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol. 2010;55:1318-1327.
99.
DodHSBhardwajRSajjaV. Effect of intensive lifestyle changes on endothelial function and on inflammatory markers of atherosclerosis. Am J Cardiol. 2010;105:362-367.
100.
VasaMFichtlschererSAicherA. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
101.
HillJMZalosGHalcoxJPJ. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Eng J Med. 2003;348:593-600.
102.
WernerNKosiolSSchieglT. Circulating endothelial progenitor cells and cardiovascular outcomes. N Eng J Med. 2005;353:999-1007.
103.
PadfieldGJNewbyDEMillsNL. Understanding the role of endothelial progenitor cells in percutaneous coronary intervention. J Am Coll Cardiol. 2010;55:1553-1565.
104.
GiannottiGDoerriesCMocharlaPS. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010;55:1389-397.
105.
HuangPHChenYHTsaiHY. Intake of red wine increases the number and functional capacity of circulating endothelial progenitor cells by enhancing nitric oxide bioavailability. Arterioscler Thromb Vasc Biol. 2010;30:869-877.
106.
FooSYHellerERWykrzykowskaJ. Vascular effects of a low-carbohydrate high-protein diet. PNAS. 2009;206:15418-15423.
107.
MorenoPRSanzJFusterV. Promoting mechanisms of vascular health: circulating progenitor cells, angiogenesis, and reverse cholesterol transport. J Am Coll Cardiol. 2009;53;2315-2323.
108.
SmithSR. A look at the low-carbohydrate diet. N Engl J Med. 2009;361:2286-2288.
109.
SacksFMBrayGACareyVJ. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Eng J Med. 2009;360:859-873.
110.
Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
111.
SuperkoHRKingSIII. Lipid management to reduce cardiovascular risk: a new strategy is required. Circulation. 2008;117:560-568.
112.
SuperkoHRGadesamRR. Is it particle size or number that correlates with risk for cardiovascular disease?Curr Atheroscler Rep. 2008;10:377-385.
113.
CromwellWCOtvosJDKeyesMJ. LDL particle number and risk of future cardiovascular disease in the Framingham Offspring Study—implications for LDL management. J Clin Lipidol. 2007;1:583-592.
114.
KwiterovichPOJr. Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity. Am J Cardiol. 2002;90:30i-47i.
115.
BlakeGJOtvosJDRifaiNRidkerPM. Low-density lipoprotein particle concentration, and size as determined by nuclear magnetic resonance spectroscopy as predictors of cardiovascular disease in women. Circulation. 2002;106:1930-1937.
116.
OtvosJDCollinsDFreedmanDS. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial. Circulation. 2006;113:1556-1563.
117.
MoraSOtvosJDRifaiNRosensonRSBuringJERidkerPM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009;119:931-939.
118.
MusunuruKOrho-MelanderMCaulfieldMP. Ion mobility analysis of lipoprotein subfractions identifies three independent axes of cardiovascular risk. Arterioscler Thromb Vasc Biol. 2009;29:1975-1980.
119.
AdielsMOlofssonS-OTaskinenM-JBorénJ. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28:1225-1236.
120.
MoraSOtvosJDRosensonRSPradhanABuringJERidkerPM. Lipoprotein particle size and concentration by nuclear magnetic resonance and incident type 2 diabetes in women. Diabetes. 2010;59:1153-1160.
121.
de SouzaJAVindisCNègre-SalvayreA. Small, dense HDL3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J Cell Mol Med. 2010;14:608-620.
122.
KraussRMBlanchePJRawlingsRSFernstromHSWilliamsPT. Separate effects of reduced carbohydrate intake and weight loss on atherogenic dyslipidemia. Am J Clin Nutr. 2006;83:1025-1031.
VolekJSPhinneySDForsytheCE. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44:297-309.
125.
WestmanECFeinmanRDMavropoulosJC. Low-carbohydrate nutrition and metabolism. Am J Clin Nutr. 2007;86:276-284.
126.
VolekJSFeinmanRD. Carbohydrate restriction improves the features of metabolic syndrome: metabolic syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond). 2005;2:31.
127.
ForsytheCEPhilleySDFernandezML. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids. 2008;43:65-77.
128.
AccursoABernsteinRKDahlqvistA. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond). 2008;5:9.
129.
FeinmanRDVolekJS. Carbohydrate restriction as the default treatment for type 2 diabetes and metabolic syndrome. Scand Cardiovasc J. 2008;42:256-263.
130.
VolekJSForsytheCE. The case for not restricting saturated fat on a low carbohydrate diet. Nutr Metab (Lond). 2005;2:21.
131.
DavisNJTomutaNSchechterC. Comparative study of the effects of a 1-year dietary intervention of a low-carbohydrate diet versus a low-fat diet on weight and glycemic control in type 2 diabetes. Diabetes Care. 2009;32:1147-1152.
132.
FeinglosMNTottenSE. Are you what you eat, or how much you eat? The case of type 2 diabetes mellitus. Arch Intern Med. 2008;168:1485-1486.
133.
KulkarniKRGarberDWMarcovinaSMSegrestJP. Quantification of cholesterol in all lipoprotein classes by VAP II method. J Lipid Res.1994;35:159-168.
134.
WillettWC. The WHI joins MRFIT: a revealing look beneath the covers. Am J Clin Nutr. 2010;91:829-830.
135.
PietiläinenKHKorkeilaMBoglLH. Inaccuracies in food and physical activity diaries of obese subjects: complementary evidence from doubly labeled water and co-twin assessments. Int J Obes. 2010;34:437-445.
136.
BeynenACKatanMBVan ZutphenLF. Hypo- and hyperresponders: individual differences in the response of serum cholesterol concentration to changes in diet. Adv Lipid Res. 1987;22:115-171.
137.
KatanMBvan GastelACde RoverCMvan MontfortMAKnuimanJT. Differences in individual responsiveness of serum cholesterol to fat-modified diets in man. Eur J Clin Invest. 1988;18:644-647.
138.
DenkeMA. Review of human studies evaluating individual dietary responsiveness in patients with hypercholesterolemia. Am J Clin Nutr. 1995;62:471S-477S.
139.
McLaughlinTAbbasiFLamendolaCReavenG. Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity. Arch Intern Med. 2007;167:642-648.
140.
HoytCSBillsonFA. Low-carbohydrate diet optic neuropathy. Med J Aust. 1977;1:65-66.
141.
FosterGDWyattHRHillJO. Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: A randomized trial. Ann Intern Med. 2010;153:147-157.
142.
VergeerMHolleboomAGKasteleinJJPKuivenhovenJA. HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?. J Lipid Res. 2010;51:2058-2073.
143.
NatarajanPRayKKCannonCP. High-Density Lipoprotein and Coronary Heart Disease. Current and Future Therapies. J Am Coll Cardiol. 2010;55:1283-1299.
144.
DodaniSGriceSDJoshiS. Is HDL function as important as HDL quantity in the coronary artery disease risk assessment?. J Clin Lipidol. 2009;3:70-77.
145.
JenkinsDJAWongJMWKendallCWC. The Effect of a Plant-based Low-Carbohydrate (Eco-Atkins) Diet on Body Weight and Blood Lipid Concentrations in Hyperlipidemic Subjects. Arch Intern Med. 2009;169:1046-1054.
146.
BradleyUSpenceMCourtneyCH. Low-fat versus low-carbohydrate weight reductions diets: Effects on weight loss, insulin resistance, and cardiovascular risk: a randomized controlled trial. Diabetes. 2009;58:2741-2748.